An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
GlobalData on MSN21h
Alphamab doses first subject in trial of JSKN003 for ovarian cancerAlphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback